Background/Aims: The long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is overexpressed in numerous cancers. However, whether MALAT1 is regulated and the related mechanisms in gastric cancer remain unclear. Methods: UPF1 and MALAT1 in gastric cancer and adjacent normal tissues. MTT, cell cycle, apoptosis and transwell assays were performed to examine the effects of UPF1 on cell cycle progression, was used to test the promoter hypermethylation on UPF1 in gastric tumor tissues. Finally, RNA immunoprecipitation and luciferase reporter analyses demonstrated that UPF1 directly bound with MALAT1. Results: cancer and negatively correlated with MALAT1 expression. Patients with lower expression of UPF1 had poorer prognosis than those with higher expression. Overexpression of UPF1 inhibited cell proliferation, cell cycle progression, cell migration and invasion, and promoted cell apoptosis in gastric cancer cells. Moreover, the UPF1-mediated inhibition of gastric cancer progression was reversed by overexpression of MALAT1. A profound downregulation of UPF1 in gastric tumor tissues was due to promoter hypermethylation. Overexpression of UPF1 of MALAT1. Conclusion: Our results demonstrate that UPF1 is a potential modulator of MALAT1 and that UPF1/MALAT1 pathway could be a therapeutic target for gastric cancer.
once the metastasis has happened and hold a poor prognosis [2] . However, the detailed mechanisms remain to be elucidated. Long non-coding RNAs (lncRNAs) are a class of non-coding RNA longer than 200 nucleotides with limited protein coding ability, and act as new modulators in various biological processes, especially in cancers [3, 4] . Metastasis associated lung adenocarcinoma cancers, such as non-small cell lung carcinoma (NSCLC) [5] , breast cancer [6] , hepatocellular carcinoma [7] and gastric cancer [8] . MALAT1 could promote cell proliferation [9] , metastasis and invasiveness of gastric adenocarcinoma [10] . However, the mechanisms by which MALAT1 is regulated in gastric cancer are inadequate.
Nonsense-mediated mRNA decay (NMD) pathway is an mRNA surveillance pathway that controls aberrant mRNA transcripts harboring premature termination codons (PTCs), and thus eliminates the synthesis of potential truncated proteins [11] . Importantly, recent study has indicated that NMD is not only a degradation pathway, but also modulates normal gene expression [12] . UPF1 is the core part of human NMD machinery and degrades mRNA transcripts that bind to RNA binding protein Staufen 1 [13] . In addition, UPF1 is essential for accomplishing DNA replication during S phase of the cell cycle [14] . Also, UPF1 is also involved in cell proliferation and differentiation by promoting the proliferative, undifferentiation state or the decay of mRNAs encoding many other proteins that oppose the proliferative, undifferentiated cell state [15] . Another study has shown that UPF1 is down-regulated and commonly mutated in pancreatic adenosquamous carcinoma [16] . However, no studies have investigated the exact activities of UPF1 in human gastric cancer, which promotes us to explore its roles in gastric cancer.
cancer tissues compared with the adjacent normal tissues, and negatively correlated with MALAT1 expression. The connection between UPF1 and MALAT1 in gastric cancer tissues promoted us to investigate whether NMD might be involved in the regulation of MALAT1 in gastric cancer. And further functional and mechanistic assays revealed that UPF1 directly binds with MALAT1 and promotes its degradation. Finally, we aimed to indicate that UPF1 MALAT1 and UPF1/MALAT1 pathway acts as a way for cells to downregulate the expression new therapeutic target for gastric cancer progression.
Material and Methods
Gastric clinical samples and cells culture with stage T, 13 patients were diagnosed with stage N and 14 patients were diagnosed with stage M. Written informed consent from all patients and approval of the Hospital Ethic Review Committees were obtained. The median follow-up time of the included patients was 8 years and the overall survival was used to compare prognosis and survival. And the mean value was regarded as the cut-off. The human gastric cancer cell lines BGC-823 and SGC-7901 were purchased from the China Academia Sinica Cell Repository Fluorescent cell sorting was used to select cells infected with Lenti-UPF1.
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay
seeded in 96-well plates at 3000-5000 cells/well. After 24, 48 h and 72 h, the growth rates were determined. Triplicate experiments were performed for each assay. 
Cell apoptosis assay

RNA immunoprecipitation (RIP)
This process was referred to lysed with 25 mM Tris-HCl buffer (pH 7.5) and 100 U/ml RNase inhibitor (Sigma), and then incubated with °C. The RNA-protein complexes were pulled-down by protein A/G agarose beads and RNA was extracted with
Quantitative real-time PCR (qRT-PCR)
total RNA was reverse transcribed into cDNA with random primer using M-MLV (Promega, USA) following the standard protocols. Afterwards, the mRNA expression levels were detected according to the protocols of SYBR Green master mix (Thermo) and performed on an ABI Prism 7500 Detection System (Applied Bi- osystems, Inc., USA). Then, the expression of each transcript was calculated using the 2 -ct method. The primers were described in Table 1 .
mRNA stability assay Gastric cancer cells with UPF1 stable expression or not were -ma) into the medium. Then total RNA was harvested at indicated times and mRNA expression was examined by qRT-PCR. The mRNA half-life was determined by comparing to the mRNA level before adding ActD.
Luciferase Reporter Assay MALAT1 promoter sequence was introduced into the pGL3 vector (Promega) for MALAT1 promoter transcriptional activity assay. Table 1 . Primer sequences used for qRT-PCR manufacturer's protocols. PCR products were subcloned, and constructs with each region from each sample was used to analyse DNA methylation data.
Western blotting
Detailed procedure was described elsewhere [18] . The antibodies against UPF1 (ab109363) E-Cadherin against Bcl-2 (#4223) and Bax (#2774) were purchased from Cell Signaling Technology. Chemiluminescence
Immunohistochemistry
The concrete procedures were referred to the previous study [19] . Immunohistochemical stainings of gastric tumors and adjacent normal tissues for UPF1 were performed using an anti-UPF1 antibody (ab109363) and related secondary goat anti-rat antibody (ab7010). DAB staining was used for immunohistochemistry assay. Image-pro Plus software was used to evaluate and then compare the IHCaverage and standard deviation of the same experimental section of each photo. Use statistical methods differences between the mean values.
Results
Immunohistochemistry staining was performed to detect the expression of UPF1 in human gastric tumor and adjacent normal tissues. UPF1 expression was higher in adjacent normal tissues than in gastric tumor tissues (Fig. 1A and 1B) . qRT-PCR was used to further examine the expression levels of UPF1 and MALAT1. As shown in Fig. 1C and 1D , in consistent in normal gastric tissues, while the expression of MALAT1 was decreased. In addition, the expression levels of UPF1 and MALAT were negatively correlated in gastric tumor samples (Fig. 1E ). And patients with lower expression of UPF1 have poorer prognosis than those with higher expression (Fig. 1F and 1G ). Further in vitro experiments showed that UPF1 expression was remarkably decreased in gastric cancer cells compared with that in gastric epithelial cells, while MALAT1 exhibited the opposite results ( Fig. 1H and 1I ). These results suggest that UPF1 may hold suppressive and MALAT1-related roles in gastric cancer progression.
Overexpression of UPF1 inhibits cell proliferation, cell cycle progression and promotes cell apoptosis in gastric cancer cells
Given the downregulation of UPF1 expression in gastric cancer tissues and cells, we constructed gastric cancer cells with stable overexpression of UPF1 using lentivirus infection. The mRNA and protein levels of UPF1 were remarkably upregulated in BGC-823 and SGC-7901 cells with UPF1 stable overexpression ( Fig. 2A and 2B ). Then MTT assay was conducted to detect the effects of UPF1 on cell proliferation. As shown in Fig. 2C and 2D, overexpression cell cycle arrest and apoptotic cells were observed in UPF1 overexpression cells (Fig. 2E-H) . Meanwhile, the mRNA and protein levels of anti-apoptotic protein (Bcl-2) and proapoptotic protein (Bax) were measured by qRT-PCR and western blot. In accordance with the above results, the expression levels of Bcl-2 were downregulated, while Bax expression proliferation, cell cycle progression and promote cell apoptosis.
Overexpression of UPF1 inhibits cell migration, invasion and epithelial-mesenchymal transition (EMT) in gastric cancer cells
Next, the effects of UPF1 on gastric tumor metastasis were further evaluated by transwell migration and invasion assays. As shown in Fig. 3A and 3B, the UPF1 overexpressed plays a vital role in tumor metastasis, the effects of UPF1 on EMT were further examined in gastric cancer cells. As expected, overexpression of UPF1 suppressed the expression of contributes to gastric tumorigenesis [20] and UPF1 hypermethylation has been shown in hepatocellular carcinoma [21] . To investigate the underlying mechanism responsible for UPF1 downregulation in gastric tumor, we detected whether hypermethylation was involved in the progression. Several CpG islands were shown in promoter region of UPF1 with MethPrimer software assay. Thus, we speculated that hypermethylation may take a critical role in regulating of UPF1 expression. As shown in Fig. 4A , the mRNA and protein expression levels of UPF1 were gradually increased in BGC-823 and SGC-7901 cells following inhibitor and can demethylate genomic DNA. To further explore the relationship between promoter methylation and UPF1 gene downregulation, CpG island prediction software enriched in the a putative promoter region of UPF1 (Fig. 4B) . Furthermore, the fragment a representative methylation pattern of the CpGs putative promoter region, and the majority of CpGs were unmethylated in normal tissues, whereas most of the CpGs were methylated in the tumor tissues.
UPF1 suppresses gastric tumorigenesis by directly binding MALAT1
As UPF1 serves as an important factor in surveillance pathway which could target and thus downreuglate aberrant genes expression in tumors [22] . Whether UPF1 affects MALAT1 expression in gastric tumor progression? This promoted us to investigate the relationship between UPF1 and MALAT1 in gastric cancer. qRT-PCR analysis showed that MALAT1 expression level was downregulated in cells with UPF1 overexpression in BGC-823 and SGC-7901 (Fig. 5A) , whereas UPF1 knockdown in GES-1 cells increased MALAT1 expression (Fig.  5B) . The mRNA stability of MALAT1 was further tested in gastric tumor cells with UPF1 overexpression and gastric epithelial cells with UPF1 knockdown. As expected, the decay rate of MALAT1 was increased in in BGC-823 and SGC-7901 cells with UPF1 overexpression (t 1/2 1/2 1/2 1/2 in SGC-7901 cells), but decreased in GES-1 cells with UPF1 knockdown (t 1/2 t 1/2 promoter transcriptional activity was not affected by UPF1 (Fig. 5F ), demonstrating that UPF1 could not alter the transcriptional activity of MALAT1. In addition, to investigate whether UPF1 bound to MALAT1, UPF1-binding complex with UPF1 antibody in BGC-823 and SGC-7901 cells with UPF1 overexpression was pull down, followed by examination the bound mRNAs by qRT-PCR. As shown in Fig. 5G and 5H, RIP assays indicated that the UPF1 attenuated or even reversed UPF1-mediated inhibitions on gastric tumor cell proliferation, EMT and the promotion on cell apoptosis (Fig. 5I-L) . Therefore, these results indicate that UPF1 interacts and inhibits MALAT1 expression, and thus exerts inhibitory effects on gastric tumor progression in a MALAT1-dependent way.
Overexpression of UPF1 enhances chemotherapeutical sensitivity in gastric cancer cells
We further explored whether ectopic expression of UPF1 affects the chemotherapeutical sensitivity of gastric cancer cells. MTT assays showed that BGC-823 and SGC-7901 cells with UPF1 overexpression displayed high doxorubicin sensitivity (Fig. 6A) . Meanwhile, when treated with doxorubicin, BGC-823 and SGC-7901 cells showed a decrease of cells in S phase, while BGC-823 and SGC-7901 cells with UPF1 overexpression showed a higher change (Fig.  6B ). In addition, upregulating UPF1 in BGC-823 and SGC-7901 cells promoted apoptosis induced by doxorubicin treatment (Fig. 6C) . The protein levels of apoptotic markers (Bcl-2 and Bax) were examined by western blot. As shown in Fig. 6D , exposure of cells with UPF1 overexpression to doxorubicin increased the expression of Bax and decreased Bcl-2 expression. Hence, these results indicate that enforced expression of UPF1 could enhance doxorubicin sensitivity in BGC-823 and SGC-7901 cells.
Discussion
Here, we reported the correlation between UPF1 downregulation and gastric tumors. Immunohistochemical analysis, western blot and qRT-PCR analyses showed that the downregulation of UPF1 expression was associated with malignant progression of gastric tumor. Epigenetic silencing of UPF1 gene was observed in gastric tumor cell lines. In MALAT1 expression in gastric cancer cells. And UPF1 exerted its inhibitory effects on gastric tumor progression in a MALAT1-dependent manner. Notably, we demonstrated that enforced expression of UPF1 could enhance doxorubicin sensitivity in BGC-823 and SGC-7901 cells. Therefore, we strongly believed that UPF1 downregulation may be required for gastric tumorigenesis and has a potential to be developed as a biomarker for gastric tumor. However, it still needs reasonable clinical trials for evaluation of this biomarker for future application.
Previous studies have shown that demethylation of oncogenes or hypermethylation of tumor suppressors contributed to tumorigenesis [20, 23] . Tumor-related hypomethylation that UPF1 is a potential suppressor in gastric tumor, which holds inhibitory effects on gastric cancer cell proliferation, cell cycle progression and migration. Importantly, promoter region was found to be hypermethylated and treatment with 5-Ad reversed the expression of UPF1, demonstrating that UPF1 expression was also affected by the status of DNA demethylation. on the role of coding genes and lncRNAs are generally considered as non-functional genes which could not code proteins or code truncated proteins [26, 27] . Indeed, the recent explosion in knowledge demonstrating the importance of lncRNAs in diseases, especially in cancer, has brought these heretofore neglected molecules to the forefront. Numerous studies have indicated that lncRNAs play important roles in tumor development. For examples, lncRNA MALAT1 could induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42 [28] . MALAT1-derived mascRNA is involved in cardiovascular innate immunity [29] . And downregulation of MALAT1 affects proliferation and the expression of stemness markers in glioma stem cell line SHG139S [30] . In addition, the potential employment of lncRNAs as novel biomarkers is supported by widespread observations [31] . Previous study has indicated the promotive roles of MALAT1 of MALAT1 could attenuate or even reverse the inhibitory effects of UPF1 on gastric tumor.
MALAT1 may help us identify novel biomarkers for gastric cancer diagnosis and present new opportunities for MALAT1-based targeted therapy.
To prevent the accumulation of truncated proteins, aberrant mRNAs containing premature termination codons could be degraded by NMD, which is an evolutionally mechanism controlling mRNA quality [32] . UPF1, UPF2 and UPF3 make up the NMD machinery and UPF1 is a critical member in this protein set. UPF1 works together with eRF1/ eRF3 to distinguish aberrant translation termination events and, in concert with UPF2 and UPF3, triggers mRNA degradation [33] . Upf1-bound transcripts support the contribution of NMD to epileptogenesis [34] . More importantly, UPF1 also modulates RNA transcripts in a NMD-independent way. For example, UPF1 regulates tumorigenesis by targeting Smad7 in hepatocellular carcinoma [21] . And UPF1 regulates myeloid cell functions and S100A9 expression by the hnRNP E2/miRNA-328 balance [35] . In this study, we found that UPF1 was also downregulated in gastric cancer. Notably, we showed that UPF1 could promote MALAT1 mRNA degradation and thus inhibit MALAT1 expression in gastric cancer. However, in the present study, we did not investigate the detailed binding sites of UPF1 in MALAT1, which should be explored in the following studies, and the future researches should be performed in vivo and other tumors. All together, our results indicated that UPF1 played an important role during gastric carcinogenesis and may serve as a putative target for gastric cancer diagnosis and therapy.
